Ana Cardus Figueras

Ana Cardus Figueras

Auto-generated profile, based on publicly available information

Ana Cardus Figueras

UK Dementia Research Institute at Cardiff University Cardiff University Cardiff UK

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 March 2019 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
JTJason P. Twohig
Jason P. Twohig
AFAna Cardus Figueras
Ana Cardus Figueras
RARobert Andrews
Robert Andrews
FWFlorian Wiede
Florian Wiede
BCBenjamin C. Cossins
Benjamin C. Cossins
SJSimon A. Jones
Simon A. Jones

1 December 2021 in Cytokine
Verified
Journal Article
Open access
RJRobert Jenkins
Robert Jenkins
SHStuart T.O. Hughes
Stuart T.O. Hughes
AFAna Cardus Figueras
Ana Cardus Figueras
SJSimon A. Jones
Simon A. Jones
The classification of interleukin-6 (IL-6) as a pro-inflammatory cytokine undervalues the biological impact of this cytokine in health and disease. With broad activities affecting the immune system, tissue homeostasis and metabolic processes, IL-6 displays complex biology. The significance of these involvements has become increasingly important in clinical settings where IL-6 is identified as a prominent target for therapy. Here, clinical experience with IL-6 antagonists emphasises the need to understand the context-dependent properties of IL-6 within an inflammatory environment and the anticipated or unexpected consequences of IL-6 blockade. In this review, we will describe the immunobiology of IL-6 and explore the gamut of IL-6 bioactivity affecting the clinical response to biological drugs targeting this cytokine pathway.

13 July 2023 in eLife
Verified
Journal Article
Open access
MCMathew Clement
Mathew Clement
KLKristin Ladell
Kristin Ladell
KMKelly L Miners
Kelly L Miners
MMMorgan Marsden
Morgan Marsden
LCLucy Chapman
Lucy Chapman
IHIan Humphreys
Ian Humphreys
Inhibitory CD4+ T cells have been linked with suboptimal immune responses against cancer and pathogen chronicity. However, the mechanisms that underpin the development of these regulatory cells, especially in the context of ongoing antigen exposure, have remained obscure. To address this knowledge gap, we undertook a comprehensive functional, phenotypic, and transcriptomic analysis of interleukin (IL)-10-producing CD4+ T cells induced by chronic infection with murine cytomegalovirus (MCMV). We identified these cells as clonally expanded and highly differentiated TH1-like cells that developed in a T-bet-dependent manner and coexpressed arginase-1 (Arg1), which promotes the catalytic breakdown of L-arginine. Mice lacking Arg1-expressing CD4+ T cells exhibited more robust antiviral immunity and were better able to control MCMV. Conditional deletion of T-bet in the CD4+ lineage suppressed the development of these inhibitory cells and also enhanced immune control of MCMV. Collectively, these data elucidated the ontogeny of IL-10-producing CD4+ T cells and revealed a previously unappreciated mechanism of immune regulation, whereby viral persistence was facilitated by the site-specific delivery of Arg1.

4 September 2025 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
CTChristopher P. Thomas
Christopher P. Thomas
VTVictoria J. Tyrrell
Victoria J. Tyrrell
JBJames J. Burston
James J. Burston
SJSam R. C. Johnson
Sam R. C. Johnson
MAMaceler Aldrovandi
Maceler Aldrovandi
VOValerie B. O’Donnell
Valerie B. O’Donnell
12/15-lipoxygenase (12/15-LOX, Alox15 ) generates bioactive oxygenated lipids during inflammation, however its homeostatic role(s) in normal healing are unclear. Here, the role of 12/15-LOX in resolving skin wounds was elucidated, focusing on how its lipids act together in physiologically relevant amounts. In mice, wounding caused acute appearance of 12/15-LOX-expressing macrophages and stem cells, coupled to early generation of ~12 monohydroxy-oxylipins and enzymatically oxidized phospholipids (eoxPL). Alox15 deletion increased collagen deposition, stem cell/fibroblast proliferation, IL6/pSTAT3, pSMAD3, and interferon (IFN)-γ levels. Conversely, CD206 expression, F480+ cells, and MMP9 and MMP2 activities were reduced. Alox15 −/− skin was deficient in PPARγ/adiponectin activity. Furthermore, while pro-inflammatory genes were upregulated as normal during wounding, many including Il6, Il1b, ccl4, Cd14, Cd274, Clec4d, Clec4e, Csf3, Cxcl2, and miR-21 failed to revert to baseline during healing, indicating disruption of PPARγ’s anti-inflammatory brake on NLRP3/inflammasome and TGF-β signaling. Reconstituting Alox15 −/− wounds with a physiological mixture of Alox15 -derived primary oxylipins generated by healing wounds restored MMP and dampened collagen deposition. The oxylipin mixture activated the PPARγ response element in vitro, while in vivo, its coactivator, Helz2 , was significantly upregulated as well as several fatty acid and prostaglandin PPARγ ligands. Additional inflammatory and proliferative gene networks impacted by Alox15 −/− included Elf4, Cebpb , and Tcf3. In summary, 12/15-LOX generates abundant monohydroxy oxylipins that act together via PPARγ. The identification of multiple gene alterations reveals several targets for treating nonhealing wounds. Our studies demonstrate that 12/15-LOX oxylipins act in concert, dampening inflammation in vivo, revealing the need to consider lipid signaling holistically.

5 June 2023 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
DMDavid Millrine
David Millrine
AFAna Cardus Figueras
Ana Cardus Figueras
JFJavier Uceda Fernandez
Javier Uceda Fernandez
RARobert Andrews
Robert Andrews
BSBarbara Szomolay
Barbara Szomolay
SJSimon A Jones
Simon A Jones
Cytokines that signal via STAT1 and STAT3 transcription factors instruct decisions affecting tissue homeostasis, antimicrobial host defense, and inflammation-induced tissue injury. To understand the coordination of these activities, we applied RNA sequencing, chromatin immunoprecipitation sequencing, and assay for transposase-accessible chromatin with high-throughput sequencing to identify the transcriptional output of STAT1 and STAT3 in peritoneal tissues from mice during acute resolving inflammation and inflammation primed to drive fibrosis. Bioinformatics focused on the transcriptional signature of the immunomodulatory cytokine IL-6 in both settings and examined how profibrotic IFN-γ–secreting CD4+ T cells altered the interpretation of STAT1 and STAT3 cytokine cues. In resolving inflammation, STAT1 and STAT3 cooperated to drive stromal gene expression affecting antimicrobial immunity and tissue homeostasis. The introduction of IFN-γ–secreting CD4+ T cells altered this transcriptional program and channeled STAT1 and STAT3 to a previously latent IFN-γ activation site motif in Alu-like elements. STAT1 and STAT3 binding to this conserved sequence revealed evidence of reciprocal cross-regulation and gene signatures relevant to pathophysiology. Thus, we propose that effector T cells retune the transcriptional output of IL-6 by shaping a regulatory interplay between STAT1 and STAT3 in inflammation.

18 July 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
DMDavid Millrine
David Millrine
AFAna Cardus Figueras
Ana Cardus Figueras
JFJavier Uceda Fernandez
Javier Uceda Fernandez
RARobert Andrews
Robert Andrews
Barbara SzomolayBarbara Szomolay
Barbara Szomolay
SJSimon A Jones
Simon A Jones
Cytokines that signal via STAT1 and STAT3 transcription factors instruct decisions affecting tissue homeostasis, anti-microbial host defense, and inflammation-induced tissue injury. To understand the coordination of these activities, we applied RNA-seq, ChIP-seq, and ATAC-seq to identify the transcriptional output of STAT1 and STAT3 in peritoneal tissues during acute resolving inflammation and inflammation primed to drive fibrosis. Bioinformatics focussed on the transcriptional signature of the immuno-modulatory cytokine IL-6 in both settings and examined how pro-fibrotic IFNγ-secreting CD4 + T-cells altered the interpretation of STAT1 and STAT3 cytokine cues. In resolving inflammation, STAT1 and STAT3 cooperated to drive stromal gene expression affecting anti-microbial immunity and tissue homeostasis. The introduction of IFNγ-secreting CD4 + T-cells altered this transcriptional program and channeled STAT1 and STAT3 to a previously latent GAS motif in Alu -like elements. STAT1 and STAT3 binding to this conserved sequence revealed evidence of reciprocal cross-regulation and gene signatures relevant to pathophysiology. Thus, we propose that effector T-cells re-tune the transcriptional output of IL-6 by shaping a regulatory interplay between STAT1 and STAT3 in inflammation.